8
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls

, , , , &
Pages 503-509 | Published online: 08 Jul 2009

REFERENCES

  • Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451–61.
  • Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman WP, Finley JC, Grayston JT. Confirmed previous infection with Chlamydia pneumonaie (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998; 98: 628–33.
  • Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273–8.
  • Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong YK, Zhou X, Ward M. Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J 2002; 23: 371–5.
  • Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. Br Med J 2000; 321(7255): 208–13.
  • Kuo CC, Coulson AS, Campbell LE, Cappuccio AL, Lawrence RD, Wang SP, Grayston JT. Detection of Chlamydia pneumoniae in athero-sclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for aterial obstruction. J Vasc Surg 1997; 26: 29–31.
  • Kuo CC, Campbell LE. Is infection with Chla-mydia pneumoniae a causative agent in athero-sclerosis. Mol Med Today 1998; 10: 426–30.
  • Fong IW, Chiu B, Viira E, Fong MW, Jong D, Mahony J. Rabbit model for Chlamydia pneumo-niae infection. J Clin Microbiol 1997; 35: 48–52.
  • Muhlestein JB, Anderson JL, Hammond EH, Zau L, Trehan S, Carlquist JF. Infection with Chlamydia pneumoniae accelerates the develop-ment of atherosclerosis and treatment with azithro-mycin prevents it in a rabbit model. Circulation 1998; 97: 633–6.
  • Gupta S. Elevated Chlamydia pneumoniae anti-bodies, cardiovascular events, and azithromyzin in male survivors of myocardial infarction. Circula-tion 1997; 96: 404–7.
  • Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromyzin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404–7.
  • Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, Vigo R, Mayer EL, Selhub J, Kutner M, Jacobsen DW. Hyperhomo-cysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996; 94: 2743–8.
  • Stenvinkel P, Heimbfirger 0, Jogerstrand T, Kämell A, Samuelsson A. Does persistent infec-tion with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure. Kidney Int 1999; 6: 2531–2.
  • Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, Paroni R, Malatino LS. Inflammation is associated with carotid athero-sclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens 2000; 18: 1207–13.
  • Condos R, McClune A, Rom WN, Schluger NW. Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis. Lancet 1996; 347: 1082–5.
  • Boehringer Mannheim. PCR applications manual. 1995.
  • Kubota Y. A new primer pair for detection of Chlamydia pneumoniae by polymerase chain reaction. Microbiol Immunol 1996; 40: 27–32.
  • Haranaga S, Yamaguchi H, Leparc GF, Friedman H, Yamamoto Y. Detection of Chlamydia pneu-monaie antigen in PBMNCs of healthy blood donors. Transfusion 2001; 41: 1114–9.
  • Maass M, Jahn J, Gieffers J, Dalhoff K, Katus HA, Solbach W. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis 2000; 181 Suppl. 3: 449–51.
  • Bartels C, Maass M, Bein G, Brill N, Bechtel JF, Leyh R, Sievers HH. Association of serology with the endovascular presence of Chlamydia pneumo-niae and cytomegalovirus in coronary artery and vein graft disease. Circulation 2000; 101: 137–41.
  • Campbell LA, O'Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585–8.
  • Wong YK, Dawkins KD, Ward ME. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999; 34: 1435–9.
  • Boman J, Gaydos CA. Polymerase chain reaction of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 2000; 181 Supp 3: 452–4.
  • Boman J, Gaydos CA, Quinn TC. Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol 1999; 37: 3791–9.
  • Zydlewski AW, Stothard DR, van der Pol B, Jones RB, Fib o RS, Hasbargen JA. Is there a role for Chlamydia pneumoniae in hemodialysis vas-cular access thrombosis? Am J Kid Dis 2000; 36: 1122–5.
  • Blasi F, Boman J, Esposito G, Melissano G, Chiesa R, Cosentini R, Tarsia P, Tshomba Y, Betti M, Alessi M, Morelli N, Allegra L. Chlamydia pneumoniae DNA detection in peri-pheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 1999; 180: 2074–6.
  • Laitinen L, Laurila AL, Leinonen M, Saikku P. Reactivation of Chlamydia pneumonaie infection in mice by cortisone treatment. Infect Immun 1996; 4: 1488–90.
  • Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endo-thelial cells and induce procoagulant activity. J Invest Med 1997; 45: 168–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.